% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Sauter:169025,
author = {M. Sauter and K. I. Foerster and J. Benzel$^*$ and S.
Pfister$^*$ and K. W. Pajtler$^*$ and W. E. Haefeli and J.
Burhenne},
title = {{B}ioanalysis of selinexor in mouse plasma micro-samples
utilizing {UPLC}-{MS}/{MS}.},
journal = {Journal of chromatography / B},
volume = {1176},
issn = {1570-0232},
address = {New York, NY [u.a.]},
publisher = {Science Direct},
reportid = {DKFZ-2021-01193},
pages = {122781},
year = {2021},
abstract = {Selinexor, a first-in-class inhibitor of the nuclear export
protein Exportin-1 (XPO1), was recently approved for the
treatment of multiple myeloma in combination with
dexamethasone, and as monotherapy for diffuse large B-cell
lymphoma. To enable investigations of selinexor in mice, we
established and validated an ultrahigh-performance liquid
chromatography - tandem mass spectrometry (UPLC-MS/MS) assay
in the plasma concentration range of 1-1000 ng/mL using
plasma microsamples of 5 µL. Protein depletion with
acetonitrile was used for efficient isolation of selinexor
which was followed by a dilution step, resulting in a
scalable sample processing. Quantification was performed
with positive electrospray ionization tandem mass
spectrometry in the selected reaction monitoring mode. Due
to the high sensitivity of the quantification and the
scalable sample processing procedure, the assay can be used
for different concentration ranges to either further
decrease the achievable lower limit of quantification or to
reduce the amount of plasma used. The assay showed interday
and intraday accuracy of $89.0-109.0\%$ with a corresponding
$precision ≤ 14.1\%.$ Suitability for investigations of
selinexor in small animal experiments was demonstrated by
determination of plasma selinexor in mice after oral
administration.},
keywords = {Bioanalysis (Other) / Pharmacokinetics (Other) / Selinexor
(Other) / Tandem Mass Spectrometry (Other) / UPLC (Other)},
cin = {B062 / HD01},
ddc = {540},
cid = {I:(DE-He78)B062-20160331 / I:(DE-He78)HD01-20160331},
pnm = {312 - Funktionelle und strukturelle Genomforschung
(POF4-312)},
pid = {G:(DE-HGF)POF4-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34051651},
doi = {10.1016/j.jchromb.2021.122781},
url = {https://inrepo02.dkfz.de/record/169025},
}